x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Eyewire News: The Podcast

Eyewire News: The Podcast keeps listeners updated with the latest information in the ophthalmic field, featuring breaking news from press releases, medical journals, vision publications, and other news sources.

news business news

All Episodes

5:18

AAO Opposes NIH Research Funding Proposal

Eyewire News: The Podcast ·

2025/02/12

The AAO responds to a proposal by the NIH to limit indirect funding for research projects; Lumenis launches a new device to address lower lid laxity and impaired blinking; and AI Optics receives FDA clearance for a handheld retinal imaging system.Learn more about your ad choices. Visit megaphone.fm/adchoices

en

4:40

FDA Approves Genentech's Susvimo Ocular Implant for DME

Eyewire News: The Podcast ·

2025/02/05

The FDA approves a label expansion for Genentech’s Susvimo implant; Iantrek completes the first commercial cases of its C.Rex micro-interventional system; and there are several executive leadership announcements made in ophthalmology.Learn more about your ad choices. Visit megaphone.fm/adchoices

en

6:10

Norlase Launches First Pattern Scanning LIO

Eyewire News: The Podcast ·

2025/01/29

The world’s first and only pattern scanning laser indirect ophthalmoscope is approved in the US and Europe; the European Commission approves a biosimilar to Eylea; and we review several clinical updates in the development of ophthalmic drugs.Learn more about your ad choices. Visit megaphone.fm/adchoices

en

5:07

Zeiss MEL 90 Approved by FDA

Eyewire News: The Podcast ·

2025/01/22

Zeiss receives a major approval for its new excimer laser;Bausch + Lomb makes two deals to bolster its pipeline in glaucoma and geographic atrophy; and Rayner announces the full European launch of its RayOne Galaxy IOLs. Learn more about your ad choices. Visit megaphone.fm/adchoices

en

8:51

Special Report – Increasing Access to Care Through...

Eyewire News: The Podcast ·

2025/01/15

Leaders from Cure Blindness Project discuss efforts to restore vision and prevent avoidable blindness in underserved communities around the world.Learn more about your ad choices. Visit megaphone.fm/adchoices

en

5:01

Glaukos Submits NDA for Epi-On CLX Candidate

Eyewire News: The Podcast ·

2025/01/08

Glaukos submits a new drug application to the FDA for its next-generation cross-linking therapy; Regeneron releases phase 3 results for Eylea HD for RVO; and Regeneron acquires a clinical stage biotech making ocular delivery technology for retinal disorders.Learn more about your ad choices. Visit megaphone.fm/adchoices

en

12:15

2024 Year in Review — Part 2

Eyewire News: The Podcast ·

2025/01/01

In today’s episode, we review the top stories from the second half of 2024. The last six months saw the launch of first-of-its-kind IOLS; the clinical advancement of gene therapies for rare diseases; the FDA approval of a device to treat patients with dry AMD; and introduction of novel OCTA technology. Learn more about your ad choices. Visit megaphone.fm/adchoices

en

11:27

2024 Year in Review — Part 1

Eyewire News: The Podcast ·

2024/12/25

In today’s broadcast, we look back at the top stories from the first half of 2024. There were several advancements made during the first six months., including the approval of an excimer laser platform; the global adoption of sustained-released anti-VEGF treatments for retinal diseases; the rollout of autonomous AI screening technology; and a total solar eclipse.Learn more about your ad choices. Visit megaphone.fm/adchoices

en

4:16

B+L Bolsters Glaucoma Offerings with Elios Acquisition

Eyewire News: The Podcast ·

2024/12/18

Bausch + Lomb makes an acquisition to expand its glaucoma offerings; Roche gets a major approval in Europe for Vabysmo; and EssilorLuxottica buys a maker of noninvasive ophthalmic medical devices. Learn more about your ad choices. Visit megaphone.fm/adchoices

en

4:52

Phase 3 Results for Novel Sedation Tablet

Eyewire News: The Podcast ·

2024/12/11

New phase 3 data is released for a non-opioid sedation tablet; the first patient is dosed in the phase 3 trial of EyePoint’s wet AMD candidate; and Outlook receives a reimbursement decision in the UK for its wet AMD treatment.Learn more about your ad choices. Visit megaphone.fm/adchoices

en

4:21

Phakic IOL for Presbyopia Approved in Europe

Eyewire News: The Podcast ·

2024/12/04

A new phakic IOL for presbyopia is approved in Europe; Nidek launches its preloaded Toric IOL Injection System internationally; and the FDA cleared a novel device for the treatment of Meibomian Gland Dysfunction.Learn more about your ad choices. Visit megaphone.fm/adchoices

en

7:05

Special Report: OWL Celebrates 20th Anniversary

Eyewire News: The Podcast ·

2024/11/27

Executives from Ophthalmic World Leaders discuss the history and goals of thee organization as it celebrates its 20th anniversary. Learn more about your ad choices. Visit megaphone.fm/adchoices

en

10:46

Lumithera CEO Discusses FDA Authorization for Veleda...

Eyewire News: The Podcast ·

2024/11/20

The CEO of Lumithera joins us to discuss the FDA authorization of the Veleda system for dry AMD; the FDA accepts the resubmitted NDA for dry eye disease candidate reproxalap; and Alcon launches the first contact lens designed for a 1-week replacement cycle. Learn more about your ad choices. Visit megaphone.fm/adchoices

en

15:29

Ophthalmic Executives Provide Company Updates (Part 2...

Eyewire News: The Podcast ·

2024/11/13

Leaders of several ophthalmic companies with a focus on the posterior segment provide updates on their pipeline and new products in this special edition of EyewireTV. Learn more about your ad choices. Visit megaphone.fm/adchoices

en

31:45

Ophthalmic Executives Provide Company Updates (Part 1...

Eyewire News: The Podcast ·

2024/11/06

We hear from executives representing pharma and device manufacturers in the anterior segment who provide updates on their companies’ recently launched products and those in development.

en

7:08

Posterior Segment Company Updates

Eyewire News: The Podcast ·

2024/10/30

Several companies with product candidates in the posterior segment provide updates; Ocuphire acquires an ophthalmic gene therapy company; and Astellas provides an update on its regulatory plans for GA drug avacincaptad pegol.

en

13:27

Breaking News From the AAO Meeting in Chicago

Eyewire News: The Podcast ·

2024/10/23

Eyewire News: The Podcast reports on new products and breaking news live from the American Academy of Ophthalmology meeting in Chicago.

en

4:41

B+L Receives FDA Approval for enVista Envy IOL

Eyewire News: The Podcast ·

2024/10/16

Bausch + Lomb receives FDA approval for a new IOL on its enVista platform; Nanoscope advances it gene therapy for retinitis pigmentosa; and Orasis completes a major funding round to support the launch of its presbyopia eye drop.

en

4:40

Aldeyra Resubmits NDA for DED Drug Reproxalap

Eyewire News: The Podcast ·

2024/10/09

Aldeyra resubmits its NDA for dry eye drug reproxalap; Clearside announces new phase 2b topline data for its investigational extended-release wet AMD drug; and Bausch + Lomb launches a new digital e-commerce marketplace.

en

4:18

Water-Free Ciclosporin-Based Eye Drop for DED...

Eyewire News: The Podcast ·

2024/10/02

Novaliq’s water-free ciclosporin-based eye drop for dry eye disease is approved in Europe; the FDA approves first new ophthalmic steroid in over 15 years; and the first slit-lamp mounted rebound tonometer is launched in the US and Europe.

en

68 results

Similar Podcasts

Expres Ráno

Expres FM

PBS News Hour - Full Show

PBS News

CD Voice

China Daily

Israel Today: Ongoing War Report

Noa Levi

Jeffrey Epstein: The Coverup Chronicles

Bobby Capucci